Article Information
History
- May 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Huilei Zhao, B.D.1,*,
- Shanshan Huang, M.D.2,*,
- Kaibo Mei, M.D.3,*,
- Wen Shao, B.D.2,
- Jing Zhang, M.D.4,
- Jianyong Ma, M.D.5,
- Wengen Zhu, M.D.6,
- Yuan Jiang, Ph.D.7,8,
- Peng Yu, M.D.9,✉ and
- Xiao Liu, M.D.7,8,✉
- 1Department of Anesthesiology, the Third Hospital of Nanchang, Jiangxi, 330006, China
- 2Medical college of Nanchang University, Jiangxi, 330006, China
- 3Department of Anesthesiology, the Shangrao People’s Hospital, Jiangxi, 330006, China
- 4Department of Anesthesiology, the Second Affiliated Hospital of Nanchang University, Jiangxi, 330006, China
- 5Department of Pharmacology and Systems Physiology University of Cincinnati College of Medicine, Cincinnati, OH 45267
- 6Department of Cardiology, the first affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080 China
- 7Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510080 China
- 8Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Guangzhou, China
- 9Department of Endocrine, the Second Affiliated Hospital of Nanchang University, Jiangxi, 330006, China
- ↵✉Corresponding author:
Peng Yu, Email: upeng_jxndefy{at}163.com, Xiao Liu, Email: liux587{at}mail.sysu.edu.cn
Posted May 05, 2021.
Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysis
